Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

6 analyst cuts: Morgan Stanley slashes Charles Schwab stock | Pro Recap

Published 03/30/2023, 06:12 AM
Updated 03/30/2023, 08:25 AM
© Reuters.

© Reuters.

By Davit Kirakosyan

Investing.com -- Here is your daily Pro Recap of the biggest analyst cuts you may have missed since yesterday.

Charles Schwab downgraded to Equalweight, shares fall

Morgan Stanley downgraded Charles Schwab (NYSE:SCHW) to Equalweight from Overweight and cut its price target to $68.00 from $99.00. As a result, shares fell nearly 2% pre-market today.

The company also saw price target cuts at Citi yesterday and JPMorgan last week.

As always, InvestingPro subscribers got this news first. Start your free 7-day trial to get on board.

Southern Copper downgraded to Equalweight

Morgan Stanley downgraded Southern Copper (NYSE:SCCO) to Equalweight from Overweight with a price target of $70.00, noting it now sees a more balanced risk-reward following the stock's outperformance over the last three, six, and 12 months.

According to the firm, now the stock more adequately reflects the company's strong cash generation and consistent returns to shareholders.

Nexa Resources downgraded at Morgan Stanley

Morgan Stanley downgraded Nexa Resources (NYSE:NEXA) to Underweight from Overweight and cut its price target to $5.60 from $6.00.

Given the company's latest guidance, Morgan Stanley's commodities team's new metal price forecasts, and new BRL/PEN assumptions, the firm reduced its 2023 and 2024 EBITDA estimates by approximately 40% and 5%, respectively.

3 more downgrades

Wells Fargo downgraded Xenia Hotels & Resorts (NYSE:XHR) to Equal Weight from Overweight and cut its price target of $13.00 from $18.00.

The company reported its Q4 results earlier this month, beating consensus estimates on EPS and revenues.

BofA Securities downgraded Ermenegildo Zegna (NYSE:ZGN) to Neutral from Buy while raising its price target to $13.50 from $13.00.

Evercore ISI downgraded Atreca (NASDAQ:BCEL) to In Line from Outperform and cut its price target to $1.50 from $2.00 following the company's reported Q4 earnings and ATRC-101 update yesterday.

InvestingPro | Be The First To Know

Latest comments

Buy gold to preserve your wealth- everything else will get hammered
No honour among greedy bloodsucking banks
Sell everything, dont get stuck on the fall
Love how banks can rate pther banks.
More downgrades to come… put your helmets on! Good luck everyone.. Timing is everything
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.